Suchira Bose

Suchira Bose is a Neurodegeneration Target and Discovery Leader at Eli Lilly and Company with over 25 years of research experience in both industry and academia. They have a strong background in protein biochemistry and cell biology, specializing in protein mis-folding associated with neurodegenerative diseases and pre-clinical drug discovery. Previously, Suchira held various roles at Eli Lilly, including Executive Director and Associate Vice President, where they demonstrated leadership in managing teams and advancing therapeutic projects. Suchira earned a BSc (Hons) and Ph.D. in Biochemistry from the University of Kent.